Vaccine Pharmacovigilance: Safety in numbers
Presented by Sarah Hall, Mipsol Limited
Description
| Event | Webinar |
| Type | Virtual Event |
| Language | English |
| Date(s) | 12 Apr. 2022 |
| Day(s) | 17:00 - 18:00 |
| Duration | 1 Hour |
This webinar will discuss vaccine-specific pharmacovigilance requirements in Europe during clinical development and post-authorisation. The ongoing safety assessment of the COVID vaccines will be discussed.
Vaccine Pharmacovigilance: Safety in numbers If you have any Questions about Vaccine pharmacovigilance, please submit your questions using the following link: Click Here
Programme
| 17:00 | Opening of the Webinar |
| 17:00 | Welcome and Introduction |
| 17:05 |
Vaccine pharmacovigilance requirements and differences from ‘standard’ pharmacovigilance
Sarah Hall, Mipsol Limited
|
| 17:40 |
Q&A Session
Seif Eddine Amara Madi, GSK
Sarah Hall, Mipsol Limited
|
| 18:00 | End of the Webinar |